These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 16473413

  • 21. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G, Babasyan S, Stout AE, Freer H, Rollins A, Wimer CL, Wagner B.
    Virology; 2019 May; 531():219-232. PubMed ID: 30928700
    [Abstract] [Full Text] [Related]

  • 22. Immune response against equine gammaherpesvirus in Icelandic horses.
    Svansson V, Roelse M, Olafsdóttir G, Thorsteinsdóttir L, Torfason EG, Torsteinsdóttir S.
    Vet Microbiol; 2009 Jun 12; 137(3-4):363-8. PubMed ID: 19217222
    [Abstract] [Full Text] [Related]

  • 23. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU, Learmonth GS, Gilkerson JR, Foote CE, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):59-66. PubMed ID: 16473414
    [Abstract] [Full Text] [Related]

  • 24. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL, Babasyan S, Rollins A, Freer H, Wimer CL, Perkins GA, Raza F, Osterrieder N, Wagner B.
    J Virol; 2019 Nov 15; 93(22):. PubMed ID: 31462575
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
    Ataseven VS, Dağalp SB, Güzel M, Başaran Z, Tan MT, Geraghty B.
    Res Vet Sci; 2009 Apr 15; 86(2):339-44. PubMed ID: 18649902
    [Abstract] [Full Text] [Related]

  • 26. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G, Breathnach CC, Kydd JH, Hussey SB, Mealey RM, Lunn DP.
    Vet Immunol Immunopathol; 2010 May 15; 135(1-2):108-117. PubMed ID: 20018383
    [Abstract] [Full Text] [Related]

  • 27. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH, Townsend HG, Hannant D.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):15-30. PubMed ID: 16476492
    [Abstract] [Full Text] [Related]

  • 28. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR, Studdert MJ.
    Am J Vet Res; 1984 Oct 15; 45(10):1947-52. PubMed ID: 6208822
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 30. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K, Caij B, Pensaert M, Nauwynck H.
    Vet Microbiol; 2006 Mar 31; 113(3-4):265-73. PubMed ID: 16387454
    [Abstract] [Full Text] [Related]

  • 31. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL, Schnabel CL, Perkins G, Babasyan S, Freer H, Stout AE, Rollins A, Osterrieder N, Goodman LB, Glaser A, Wagner B.
    PLoS One; 2018 Mar 31; 13(11):e0206679. PubMed ID: 30440016
    [Abstract] [Full Text] [Related]

  • 32. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
    Bell SA, Balasuriya UB, Gardner IA, Barry PA, Wilson WD, Ferraro GL, MacLachlan NJ.
    Vet Microbiol; 2006 Sep 10; 116(4):249-57. PubMed ID: 16774810
    [Abstract] [Full Text] [Related]

  • 33. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
    van der Meulen KM, Favoreel HW, Pensaert MB, Nauwynck HJ.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):31-40. PubMed ID: 16472872
    [Abstract] [Full Text] [Related]

  • 34. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
    Wimer CL, Damiani A, Osterrieder N, Wagner B.
    Vet Immunol Immunopathol; 2011 Apr 15; 140(3-4):266-74. PubMed ID: 21349590
    [Abstract] [Full Text] [Related]

  • 35. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR.
    Am J Vet Res; 1977 Jan 15; 38(1):117-21. PubMed ID: 189645
    [Abstract] [Full Text] [Related]

  • 36. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA, Tokateloff N, Manning S, Lohmann K, Lunn DP, Hussey SB, Morley PS.
    J Vet Intern Med; 2012 Jan 15; 26(2):384-92. PubMed ID: 22332764
    [Abstract] [Full Text] [Related]

  • 37. The immune response of foals to natural infection with equid herpesvirus-2 and its association with febrile illness.
    Brault SA, Blanchard MT, Gardner IA, Stott JL, Pusterla N, Mapes SM, Vernau W, Dejong KD, Maclachlan NJ.
    Vet Immunol Immunopathol; 2010 Sep 15; 137(1-2):136-41. PubMed ID: 20646766
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells.
    Sarkar S, Balasuriya UB, Horohov DW, Chambers TM.
    Vet Immunol Immunopathol; 2015 Oct 15; 167(3-4):122-9. PubMed ID: 26275803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.